Novel Mechanisms of Regulation of the Expression and Transcriptional Activity of Hepatocyte Nuclear Factor 4α

Overview

Journal J Cell Biochem

Specialties Biochemistry
Cell Biology

Date 2018 Sep 8

PMID 30191603

Citations 17

Authors

Shangdong Guo

Hong Lu

Affiliations

Soon will be listed here.

Abstract

Hepatocyte nuclear factor 4α (HNF4α) is a master regulator of development and function of digestive tissues. The HNF4A gene uses two separate promoters P1 and P2, with P1 products predominant in adult liver, whereas P2 products prevalent in fetal liver, pancreas, and liver/colon cancer. To date, the mechanisms for the regulation of HNF4A and the dynamic switch of P1-HNF4α and P2-HNF4α during ontogenesis and carcinogenesis are still obscure. Our study validated the previously reported self-stimulation of P1-HNF4α but invalidated the reported synergism between HNF4α and HNF1α. HNF4A-AS1, a long noncoding RNA, is localized between the P2 and P1 promoters of HNF4A. We identified critical roles of P1-HNF4α in regulating the expression of HNF4A-AS1 and its mouse ortholog Hnf4a-os. Paired box 6 (PAX6), a master regulator of pancreas development overexpressed in colon cancer, cooperated with HNF1α to induce P2-HNF4α but antagonized HNF4α in HNF4A-AS1 expression. Thus, PAX6 may be important in determining ontogenic and carcinogenic changes of P2-HNF4α and HNF4A-AS1 in the pancreas and intestine. We also interrogated transactivation activities on multiple gene targets by multiple known and novel HNF4α mutants identified in patients with maturity onset diabetes of the young 1 (MODY1) and liver cancer. Particularly, HNF4α-D78A and HNF4α-G79S, two mutants found in liver cancer with mutations in DNA-binding domain, displayed highly gene-specific transactivation activities. Interestingly, HNF4α-Q277X, a MODY1 truncation mutant, antagonized the transactivation activities of HNF1α and farnesoid X receptor, key regulators of insulin secretion. Taken together, our study provides novel mechanistic insights regarding the transcriptional regulation and transactivation activity of HNF4α in digestive tissues.

Citing Articles

Gut microbiota trigger host liver immune responses that affect drug-metabolising enzymes.

Rao J, Qiu P, Zhang Y, Wang X Front Immunol. 2024; 15:1511229.

PMID: 39720713 PMC: 11668346. DOI: 10.3389/fimmu.2024.1511229.

Cell-Specific Regulation of Inflammatory Cytokines and Acute-Phase Proteins by the Glucocorticoid Receptor.

Winkler R, Lu H Mediators Inflamm. 2024; 2023:4399998.

PMID: 39619227 PMC: 11606692. DOI: 10.1155/2023/4399998.

Small hepatitis B virus surface antigen (SHBs) induces dyslipidemia by suppressing apolipoprotein-AII expression through ER stress-mediated modulation of HNF4α and C/EBPγ.

Wu Y, Ren L, Mao C, Shen Z, Zhu W, Su Z J Virol. 2024; 98(11):e0123924.

PMID: 39470210 PMC: 11575332. DOI: 10.1128/jvi.01239-24.

HNF4A-AS1 inhibits the progression of hepatocellular carcinoma by promoting the ubiquitin-modulated degradation of PCBP2 and suppressing the stability of ARG2 mRNA.

Jia W, Yu L, Xu B, Feng Y, Wang J, Zhu D Int J Biol Sci. 2024; 20(13):5087-5108.

PMID: 39430249 PMC: 11488582. DOI: 10.7150/ijbs.95276.

Multiple roles and regulatory mechanisms of the transcription factor HNF4 in the intestine.

Vemuri K, Radi S, Sladek F, Verzi M Front Endocrinol (Lausanne). 2023; 14:1232569.

PMID: 37635981 PMC: 10450339. DOI: 10.3389/fendo.2023.1232569.

References

Garrison W, Battle M, Yang C, Kaestner K, Sladek F, Duncan S . Hepatocyte nuclear factor 4alpha is essential for embryonic development of the mouse colon. Gastroenterology. 2006; 130(4):1207-20. PMC: 3581272. DOI: 10.1053/j.gastro.2006.01.003. View

Raeder H, Bjorkhaug L, Johansson S, Mangseth K, Sagen J, Hunting A . A hepatocyte nuclear factor-4 alpha gene (HNF4A) P2 promoter haplotype linked with late-onset diabetes: studies of HNF4A variants in the Norwegian MODY registry. Diabetes. 2006; 55(6):1899-903. DOI: 10.2337/db05-1677. View

Lausen J, Thomas H, Lemm I, Bulman M, Borgschulze M, Lingott A . Naturally occurring mutations in the human HNF4alpha gene impair the function of the transcription factor to a varying degree. Nucleic Acids Res. 1999; 28(2):430-7. PMC: 102517. DOI: 10.1093/nar/28.2.430. View

Perilhou A, Tourrel-Cuzin C, Zhang P, Kharroubi I, Wang H, Fauveau V . The MODY1 gene for hepatocyte nuclear factor 4alpha and a feedback loop control COUP-TFII expression in pancreatic beta cells. Mol Cell Biol. 2008; 28(14):4588-97. PMC: 2447131. DOI: 10.1128/MCB.01191-07. View

Tanaka T, Jiang S, Hotta H, Takano K, Iwanari H, Sumi K . Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer. J Pathol. 2006; 208(5):662-72. DOI: 10.1002/path.1928. View

Spath G, Weiss M . Hepatocyte nuclear factor 4 expression overcomes repression of the hepatic phenotype in dedifferentiated hepatoma cells. Mol Cell Biol. 1997; 17(4):1913-22. PMC: 232038. DOI: 10.1128/MCB.17.4.1913. View

Li Y, Li Y, Liu Y, Xie P, Li F, Li G . PAX6, a novel target of microRNA-7, promotes cellular proliferation and invasion in human colorectal cancer cells. Dig Dis Sci. 2013; 59(3):598-606. DOI: 10.1007/s10620-013-2929-x. View

Suaud L, Hemimou Y, Formstecher P, LAINE B . Functional study of the E276Q mutant hepatocyte nuclear factor-4alpha found in type 1 maturity-onset diabetes of the young: impaired synergy with chicken ovalbumin upstream promoter transcription factor II on the hepatocyte nuclear factor-1 promoter. Diabetes. 1999; 48(5):1162-7. DOI: 10.2337/diabetes.48.5.1162. View

Babeu J, Boudreau F . Hepatocyte nuclear factor 4-alpha involvement in liver and intestinal inflammatory networks. World J Gastroenterol. 2014; 20(1):22-30. PMC: 3886012. DOI: 10.3748/wjg.v20.i1.22. View

10.

Lazarevich N, Shavochkina D, Fleishman D, Kustova I, Morozova O, Chuchuev E . Deregulation of hepatocyte nuclear factor 4 (HNF4)as a marker of epithelial tumors progression. Exp Oncol. 2011; 32(3):167-71. View

11.

Chellappa K, Deol P, Evans J, Vuong L, Chen G, Briancon N . Opposing roles of nuclear receptor HNF4α isoforms in colitis and colitis-associated colon cancer. Elife. 2016; 5. PMC: 4907689. DOI: 10.7554/eLife.10903. View

12.

Oshima T, Kawasaki T, Ohashi R, Hasegawa G, Jiang S, Umezu H . Downregulated P1 promoter-driven hepatocyte nuclear factor-4alpha expression in human colorectal carcinoma is a new prognostic factor against liver metastasis. Pathol Int. 2007; 57(2):82-90. DOI: 10.1111/j.1440-1827.2006.02061.x. View

13.

Kocher O, Krieger M . Role of the adaptor protein PDZK1 in controlling the HDL receptor SR-BI. Curr Opin Lipidol. 2009; 20(3):236-41. PMC: 2849150. DOI: 10.1097/MOL.0b013e32832aee82. View

14.

Vaxillaire M, Rouard M, Yamagata K, Oda N, Kaisaki P, Boriraj V . Identification of nine novel mutations in the hepatocyte nuclear factor 1 alpha gene associated with maturity-onset diabetes of the young (MODY3). Hum Mol Genet. 1997; 6(4):583-6. DOI: 10.1093/hmg/6.4.583. View

15.

Magistri M, Faghihi M, St Laurent 3rd G, Wahlestedt C . Regulation of chromatin structure by long noncoding RNAs: focus on natural antisense transcripts. Trends Genet. 2012; 28(8):389-96. PMC: 3768148. DOI: 10.1016/j.tig.2012.03.013. View

16.

Zhang Q, Lei X, Lu H . Alterations of epigenetic signatures in hepatocyte nuclear factor 4α deficient mouse liver determined by improved ChIP-qPCR and (h)MeDIP-qPCR assays. PLoS One. 2014; 9(1):e84925. PMC: 3888413. DOI: 10.1371/journal.pone.0084925. View

17.

Walesky C, Edwards G, Borude P, Gunewardena S, ONeil M, Yoo B . Hepatocyte nuclear factor 4 alpha deletion promotes diethylnitrosamine-induced hepatocellular carcinoma in rodents. Hepatology. 2013; 57(6):2480-90. PMC: 3669646. DOI: 10.1002/hep.26251. View

18.

Hatzis P, Talianidis I . Regulatory mechanisms controlling human hepatocyte nuclear factor 4alpha gene expression. Mol Cell Biol. 2001; 21(21):7320-30. PMC: 99906. DOI: 10.1128/MCB.21.21.7320-7330.2001. View

19.

Campeau P, Astapova O, Martins R, Bergeron J, Couture P, Hegele R . Clinical and molecular characterization of a severe form of partial lipodystrophy expanding the phenotype of PPARγ deficiency. J Lipid Res. 2012; 53(9):1968-78. PMC: 3413236. DOI: 10.1194/jlr.P025437. View

20.

Fang B, Mane-Padros D, Bolotin E, Jiang T, Sladek F . Identification of a binding motif specific to HNF4 by comparative analysis of multiple nuclear receptors. Nucleic Acids Res. 2012; 40(12):5343-56. PMC: 3384313. DOI: 10.1093/nar/gks190. View